This is preserved historical wording.
It is no longer the current profile. Read the canonical profile and its correction notice.
It is no longer the current profile. Read the canonical profile and its correction notice.
Update · July 27, 2026
We rewrote the profile summary to describe the cited study record more directly. The cited source and status did not change. 1
What this version reported
ClinicalTrials.gov lists an Eli Lilly study as active, not recruiting, with a registry update posted July 20, 2026.↗
Organizations named in cited records:
- Eli Lilly and Company↗
Trial records: NCT06297603
Sources for this version
- 1Retatrutide in Participants With Type 2 Diabetes and Renal Impairment · record history version 25 · last update posted 2026-07-20 ↗
ClinicalTrials.gov · Official source · Source checked July 22, 2026